Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Amphista Therapeutics

Oncology Today

Oncology Today—June 15, 2026

This week’s Oncology update highlights regulatory authorizations, clinical…

Hematology

Hematology Today — October 20, 2025

Explore this week’s Hematology highlights, including FDA updates, partnerships…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
LucidWargames
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Obesity Today—June 23, 2026
LabGenius and LG Chem Advance Multispecific Antibody Partnership | Lucid Diligence Brief
Vedana Therapeutics Advances Migraine Antibody Pipeline | Lucid Diligence Brief
Hematology Today—June 22, 2026
Oncology Today—June 22, 2026

Tags

AB-101 ABCA4 Air Quality antiretrovirals BiomX CDA-AMC CELMoD classic hodgkin lymphoma depression genetics Ebola Vaccines EP0031 Fenebrutinib Firefly Bio FoundationOne Liquid CDx gallant generalized myasthenia gravis Genital Psoriasis GI cancers Huntington’s Disease Chorea IBI363 Lumus AI MEAI Migraine therapy NEJM AI non-hodgkin lymphoma nutrition security obesity drugs OCTA imaging OPGx-RHO oracle Pancreatic Beta Cell Therapy PDE4 SERENA-6 SGAustria sk biopharm spesolimab Spyre Therapeutics Stoke Therapeutics T-CURX Tapestri TCR therapeutics Tricuspid Valve Disease Valvular heart disease Vispacabtagene Regedleucel Zopapogene Imadenovec-Drba

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Obesity Today—June 23, 2026
LabGenius and LG Chem Advance Multispecific Antibody Partnership | Lucid Diligence Brief
Vedana Therapeutics Advances Migraine Antibody Pipeline | Lucid Diligence Brief
Hematology Today—June 22, 2026
Oncology Today—June 22, 2026

TAGS

AB-101 ABCA4 Air Quality antiretrovirals BiomX CDA-AMC CELMoD classic hodgkin lymphoma depression genetics Ebola Vaccines EP0031 Fenebrutinib Firefly Bio FoundationOne Liquid CDx gallant generalized myasthenia gravis Genital Psoriasis GI cancers Huntington’s Disease Chorea IBI363 Lumus AI MEAI Migraine therapy NEJM AI non-hodgkin lymphoma nutrition security obesity drugs OCTA imaging OPGx-RHO oracle Pancreatic Beta Cell Therapy PDE4 SERENA-6 SGAustria sk biopharm spesolimab Spyre Therapeutics Stoke Therapeutics T-CURX Tapestri TCR therapeutics Tricuspid Valve Disease Valvular heart disease Vispacabtagene Regedleucel Zopapogene Imadenovec-Drba

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy